These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 21187483)
1. Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients. Shirahata A; Sakuraba K; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Hibi K Anticancer Res; 2010 Dec; 30(12):5015-8. PubMed ID: 21187483 [TBL] [Abstract][Full Text] [Related]
2. Serum vimentin methylation as a potential marker for colorectal cancer. Shirahata A; Hibi K Anticancer Res; 2014 Aug; 34(8):4121-5. PubMed ID: 25075038 [TBL] [Abstract][Full Text] [Related]
3. Vimentin methylation as a marker for advanced colorectal carcinoma. Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162 [TBL] [Abstract][Full Text] [Related]
4. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070 [TBL] [Abstract][Full Text] [Related]
5. [Fecal methylated DNA for the detection of colorectal cancer]. von Delius S; Jung A; Schmid RM Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074 [No Abstract] [Full Text] [Related]
6. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients. Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139 [TBL] [Abstract][Full Text] [Related]
7. Improved fecal DNA test for colorectal cancer screening. Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655 [TBL] [Abstract][Full Text] [Related]
8. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? Brenner DE; Rennert G J Natl Cancer Inst; 2005 Aug; 97(15):1107-9. PubMed ID: 16077063 [No Abstract] [Full Text] [Related]
9. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients. Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762 [TBL] [Abstract][Full Text] [Related]
10. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma. Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082 [TBL] [Abstract][Full Text] [Related]
11. Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer. Sakamoto J; Fujiya M; Okamoto K; Nata T; Inaba Y; Moriichi K; Tanabe H; Mizukami Y; Watari J; Ashida T; Kohgo Y Cancer Epidemiol; 2010 Apr; 34(2):194-9. PubMed ID: 20129840 [TBL] [Abstract][Full Text] [Related]
12. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557 [TBL] [Abstract][Full Text] [Related]
13. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591 [TBL] [Abstract][Full Text] [Related]
14. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997 [TBL] [Abstract][Full Text] [Related]
15. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence. Herbst A; Wallner M; Rahmig K; Stieber P; Crispin A; Lamerz R; Kolligs FT Eur J Gastroenterol Hepatol; 2009 May; 21(5):565-9. PubMed ID: 19282772 [TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of the Vimentin gene in hepatocellular carcinoma. Kitamura Y; Shirahata A; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2011 Apr; 31(4):1289-91. PubMed ID: 21508377 [TBL] [Abstract][Full Text] [Related]
17. Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406 [TBL] [Abstract][Full Text] [Related]
18. Detection of vimentin methylation in the serum of patients with gastric cancer. Shirahata A; Sakuraba K; Kitamura Y; Yokomizo K; Gotou T; Saitou M; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2012 Mar; 32(3):791-4. PubMed ID: 22399595 [TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Wiencke JK; Zheng S; Lafuente A; Lafuente MJ; Grudzen C; Wrensch MR; Miike R; Ballesta A; Trias M Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):501-6. PubMed ID: 10385139 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer. Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]